mRNA Vaccines and Therapeutics Market Share, Size, Growth, Trends and Forecast 2020-2025

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

mRNA Vaccines and Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global mRNA vaccines and therapeutics market potential is expected to reach a value of US$ 9.41 Billion in 2021. Messenger Ribonucleic Acid (mRNA) refers to a single protein-coding gene in the genome that acts as a basis for protein synthesis within the cells. mRNA vaccines and therapeutics combine the desirable immunological properties and are prepared in laboratories using mammalian cells. Some of the common types of vaccines and therapeutics include self-amplifying, non-replicating, in vivo self-replicating and in vitro dendritic cell non-replicating mRNA. They are injected into the body to trigger virus-detecting immune sensors and produce viral antigen proteins within the cells. This aids in enhancing the body’s immunity by improving B- and T-cell responses.

The rising prevalence of medical ailments, such as diabetes, tuberculosis, cancer and cardiovascular diseases (CVDs), is one of the key factors driving the growth of the market. The increasing demand for therapeutic medicines and vaccines for Ebola, influenza, Human Immunodeficiency Virus (HIV) and other viral infections is also providing a boost to the market growth. In comparison to conventional medicines, mRNA vaccines and therapeutics are developed using advanced technologies that are more effective against pathogens, have higher potency, enhanced immunogenicity and are relatively more cost-effective. Additionally, improvements in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA are also creating a positive outlook for the market. Pharmaceutical companies are investing in mRNA technologies as they can combine multiple molecules into a therapeutic medicine, which is acting as another major growth-inducing factor. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with improvements in the healthcare technologies, are projected to drive the market further. Looking forward, the market is projected to register a CAGR of 10.5% during 2021-2026, reaching a value of US$ 15.49 Billion by 2026.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global mRNA vaccines and therapeutics market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, vehicle type, product type and technology.

Breakup by Vaccine Type:

Self-amplifying mRNA-based Vaccines
Conventional Non-Amplifying mRNA-Based Vaccines

Breakup by Treatment Type:

Bioengineered Vaccine
Gene Therapy
Gene Transcription
Cell Therapy
Monoclonal Antibody
Others

Breakup by Vaccine Manufacturing:

In-House
Out-Sourced

Breakup by Application:

Cancer
Infectious Disease
Gene Editing
Protein Replacement

Breakup by End-User:

Hospitals and Clinics
Research Organizations
Others

Breakup by Region:

North America
- United States
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Arcturus Therapeutics Inc., BioNTech SE, CureVac AG, Etherna, ethris GmbH, GlaxoSmithKline PLC, Moderna Therapeutics Inc., Translate Bio Inc., Argos Therapeutics, Inc., Sangamo Therapeutics Inc., Pfizer Inc, etc.

Key Questions Answered in This Report:

How the global mRNA vaccines and therapeutics market will perform in the coming years?
What will be the key regional markets?
What will be the impact of COVID-19 on the mRNA vaccines and therapeutics market?
What will be the key vaccine types in the market?
What will be the key treatment types in the market?
What will be the key manufacturing types in the market?
What will be the applications in the market?
What will be the key end-use segments in the market?
What would be the various stages in the value chain of the industry?
What will be the key driving factors and challenges in the industry?
What will be the structure of the global mRNA vaccines and therapeutics market and who will be the key players?
What would be the degree of competition in the industry?